SavedAdd your journal

Journals / Turkish Journal of Chemistry / 2008 / Cilt: 32 - Sayı: 4

Synthesis and Antimicrobial Activity of Some 3(2H)-Pyridazinone and 1(2H)-Phthalazinone Derivatives

Deniz S. DOĞRUER
Tijen ÖNKOL
Semiha ÖZKAN
Selda ÖZGEN
M. Fethi ŞAHİN
Pages
469–479
Publication Date
2008-04-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The results showed that the synthesized compounds were generally active against B. subtilis and its clinical isolate.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Some 3(2H)-pyridazinone and 1(2H)-phthalazinone derivatives were synthesized.
📊
Key Findings & Data:The structures of these new compounds were confirmed by IR, 1H-NMR, mass spectrum, and elemental analysis.
💡
Conclusion & Impact:The results showed that the synthesized compounds were generally active against B. subtilis and its clinical isolate.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:3(2H)-pyridazinone · 1(2H)-phthalazinone · antimicrobial activity

Abstract

Some 3(2H)-pyridazinone and 1(2H)-phthalazinone derivatives were synthesized. The structures of these new compounds were confirmed by IR, 1H-NMR, mass spectrum, and elemental analysis. The synthesized compounds were evaluated for their antibacterial activity against various gram-positive and gram-negative strains of bacteria and their clinical isolates and for their antimycobacterial activity against M. tuberculosis H37Rv. The results showed that the synthesized compounds were generally active against B. subtilis and its clinical isolate. Among the target compounds, compound 14c exhibited the best antibacterial activity, with a MIC value of 15.62 m g/mL against B. subtilis. Compound 15e had the highest antimycobacterial activity.

Özet

Some 3(2H)-pyridazinone and 1(2H)-phthalazinone derivatives were synthesized. The structures of these new compounds were confirmed by IR, 1H-NMR, mass spectrum, and elemental analysis. The synthesized compounds were evaluated for their antibacterial activity against various gram-positive and gram-negative strains of bacteria and their clinical isolates and for their antimycobacterial activity against M. tuberculosis H37Rv. The results showed that the synthesized compounds were generally active against B. subtilis and its clinical isolate. Among the target compounds, compound 14c exhibited the best antibacterial activity, with a MIC value of 15.62 m g/mL against B. subtilis. Compound 15e had the highest antimycobacterial activity.

🔖

Cite This Article

DOĞRUER, D. S., ÖNKOL, T., ÖZKAN, S., ÖZGEN, S., ŞAHİN, M. F. (2008). Synthesis and Antimicrobial Activity of Some 3(2H)-Pyridazinone and 1(2H)-Phthalazinone Derivatives. Turkish Journal of Chemistry, Cilt: 32 - Sayı: 4, 469–479. https://ajindex.com/articles/185039

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Matsushita, M.; Janda, K. D. Bioorg. Med. Chem. 2002, 10, 855-867.
  2. Williams, D. A.; Lemke, T. L. Foye’s Principles of Medicinal Chemistry, 5th ed. Lippincott Williams and Wilkins, 2002.
  3. Coelho, A.; Sotelo, E.; Fraiz, N.; Yanez, M.; Laguna, R.; Canob, E.; Ravina, E. Bioorg. Med. Chem. Lett. 2004,, 321-324.
  4. Demirayak, S¸.; Karaburun, A. C.; Beis, R. Eur. J. Med. Chem. 2004, 39, 1089-1095. Do˘gruer, D. S.; S¸ahin, M. F.; ¨Unl¨u. S.; Ito, S. Arch. Pharm. Pharm. Med. Chem. 2000, 333, 79-86. Do˘gruer, D. S.; S¸ahin, M. F.; K¨upeli, E.; Ye¸silada, E. Turk. J. Chem. 2003, 27, 727-738. Do˘gruer, D. S.; K¨upeli, E.; Ye¸silada, E.; S¸ahin, M. F. Arch. Pharm. Pharm. Med. Chem. 2004, 337, 303-3107.
  5. Kassim, E. M.; Abd-El-Nour, K. N.; El-Diwany, A. I.; Abou-Aiad, T. H. Indian J. Chem. 1996, 35B, 692-696.
  6. Kassem, E. M.; Kamel, M. M.; El-Zahar, M. Pharmazie, 1990, 45, 215-216.
  7. El-Tamaty, E. S. H.; Abdel-Fattah, M. E.; El-Deen, I. M. Indian J. Chem. 1996, 35B, 1067-1072. S¨onmez, M.; Berber, I.; Akba¸s, E. Eur. J. Med. Chem. 2006, 41, 101-105.
  8. Carmellino, M. L.; Massolini, G.; Pagani, G. Il Farmaco, 1993, 48, 1427-1438.
  9. Kamal, A.; Khan, M. N. A.; Reddy, K. S.; Rohini, K. Bioorg. Med. Chem. 2007, 15, 1004-1013. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, third ed. Approved standard. NCCLS document M100-S12, Wayne, PA, USA, 2002. Clinical and Laboratory Standards Institute. Susceptibility Testing of Mycobacteria, Nocardiae, and other aerobic Actinomycetes; Approved Standard NCCLS document M24-A, Wayne 2003. Clinical and Laboratory Standards Institute (CLSI) (formerly NCCLS): Antimycobacterial susceptibility test- ing for M. tuberculosis tentative Standard NCCLS document M24-T, Villanova, PA 2002.
  10. Mogilaiah, K.; Reddy, N. V.; Reddy, G. R. Synth. Commun. 2003, 33, 3109-3113.
  11. Kane, J. M.; Huber, E. W.; Miller, F. P.; Kehne, J. H. Pharmazie 1992, 47, 249-251.
  12. Steck, E. A.; Brundage, R. P.; Fletcher, L. T. J. Am. Chem. Soc. 1953, 75, 1117-1119.
  13. Sotelo, E. Coelho, A.; Ravina, E. Tetrohedron Lett, 2003, 44, 4459-4462.
  14. Nitta, Y.; Yoneda, F.; Ohtaka, T.; Kato, T. Chem. Pharm. Bull. 1964, 12, 69-73.
  15. King, J. A. 1958, US 2832780. Abd El-Baset Hassanien, A. Z. Phosphorus, Sulfur and Silicon, 2003, 178, 1987-1997.
  16. Dimmrock, J. R.; Patil, S. A.; Sardessai, M. S.; Mazurek, M. Pharmazie, 1987, 42, 111-112.